BCL2 and hematopoietic and lymphoid cell neoplasm: The studies showed that the ABT-199 had good activity on Bcl-2-dependent hematological cancers.88 The ABT-199 showed a high affinity for Bcl-2 (Ki < 0.01 nM) and a weak affinity for Bcl-XL (Ki = 48 nM).